EUVIMEDEUVIMED entdecken
Crossref

Evaluating Serum Beta-2-Microglobulin Levels for Uremic Pericarditis Risk in End-Stage Renal Disease Patients

Jing J Zhang, Shui X Wang, Lei Zhang

Clinical Laboratory · 2025

DOI: 10.7754/clin.lab.2024.240903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Laboratory, 2025. Verfasst von Jing J Zhang und 2 weiteren Autor:innen. Hauptthemen laut MEDLINE: beta 2-Microglobulin, Kidney Failure, Chronic, Uremia, Pericarditis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The aim of this study was to investigate the clinical significance of serum β-2-microglobulin (B2M) in predicting the development of uremic pericarditis (UP) in patients with end-stage renal disease (ESRD). METHODS: Three hundred ESRD patients who started hemodialysis and underwent echocardiography were selected. The clinical data of 300 ESRD patients were obtained through the hospital medical record system. Serum B2M levels were measured 24 hours before starting hemodialysis. Risk factors for the occurrence of UP in ESRD patients were analyzed by logistic regression. Predictive value of serum B2M levels for the development of UP in ESRD patients was analyzed by ROC curve. RESULTS: Twenty-eight out of 300 ESRD patients developed UP. Serum B2M levels were higher in ESRD patients with UP. Higher serum B2M level was a risk factor for UP in ESRD patients. Serum B2M levels had a high predictive value for the development of UP in ESRD patients. CONCLUSIONS: Serum B2M levels have a high predictive value for the development of UP in ESRD patients, and high serum B2M levels are associated with UP risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta 2-MicroglobulinKidney Failure, ChronicUremiaPericarditisHumansMaleFemaleMiddle AgedRisk FactorsBiomarkersAgedRenal DialysisAdultROC CurvePredictive Value of Tests

Substanzen

beta 2-MicroglobulinBiomarkersB2M protein, human

Zitieren

APA

Zhang, J. J., Wang, S. X., & Zhang, L. (2025). Evaluating Serum Beta-2-Microglobulin Levels for Uremic Pericarditis Risk in End-Stage Renal Disease Patients. Clinical Laboratory. https://doi.org/10.7754/clin.lab.2024.240903

Vancouver

Zhang JJ, Wang SX, Zhang L. Evaluating Serum Beta-2-Microglobulin Levels for Uremic Pericarditis Risk in End-Stage Renal Disease Patients. Clinical Laboratory. 2025. doi:10.7754/clin.lab.2024.240903

BibTeX
@article{Zhang2025,
  author = {Zhang, Jing J and Wang, Shui X and Zhang, Lei},
  title = {Evaluating Serum Beta-2-Microglobulin Levels for Uremic Pericarditis Risk in End-Stage Renal Disease Patients},
  journal = {Clinical Laboratory},
  year = {2025},
  doi = {10.7754/clin.lab.2024.240903}
}
Kostenlos starten →